The capabilities of benzoporphyrin

In vivo study of canine malignant melanomas with photodynamic therapy

Cheng Jen Chang, Chen Nun Chang, Tsann Lang Hwang

Research output: Contribution to journalArticle

Abstract

Human malignant melanomas are a kind of commonly occurring neoplasm with a clinical course of recurrence after surgical removal. This preliminary animal study seeks to evaluate the effect of benzoporphyrin derivative (BPD) in photodynamic therapy (PDT) for spontaneously arising melanoma in canines. Ten dogs with spontaneously occurring melanomas were treated with PDT using BPD as the photosensitizer. BPD was injected intravenously at a dose of 1 mg/kg. Six hours later the treatment of PDT with 690 nm light was taken. Some larger tumors (>1.5 cm deep) were surgically debulked prior to PDT. No significant systemic toxicity or skin photosensitization was observed. PDT with BPD led to a complete response in 70% (7 of 10) of these cases. 20% (2 of 10) had a partial response, and 10% (1 of 10) no response (<50% reduction of tumor size). BPD-PDT appears to have advantages in the treatment of canine melanomas, and systemic toxicity is almost nonexistent. Further studies of the long term results are necessary before BPD-PDT can be used in humans.

Original languageEnglish
Pages (from-to)166-172
Number of pages7
JournalFormosan Journal of Surgery
Volume35
Issue number4
Publication statusPublished - Jan 1 2002
Externally publishedYes

Fingerprint

Photochemotherapy
Canidae
Melanoma
Photosensitivity Disorders
Neoplasms
Photosensitizing Agents
Dogs
Light
Recurrence
Skin
Therapeutics

Keywords

  • Melanoma
  • Photodynamic therapy
  • Photosensitizer

ASJC Scopus subject areas

  • Surgery

Cite this

The capabilities of benzoporphyrin : In vivo study of canine malignant melanomas with photodynamic therapy. / Chang, Cheng Jen; Chang, Chen Nun; Hwang, Tsann Lang.

In: Formosan Journal of Surgery, Vol. 35, No. 4, 01.01.2002, p. 166-172.

Research output: Contribution to journalArticle

@article{4eb0d66866c14eeda04d663c1fda20c8,
title = "The capabilities of benzoporphyrin: In vivo study of canine malignant melanomas with photodynamic therapy",
abstract = "Human malignant melanomas are a kind of commonly occurring neoplasm with a clinical course of recurrence after surgical removal. This preliminary animal study seeks to evaluate the effect of benzoporphyrin derivative (BPD) in photodynamic therapy (PDT) for spontaneously arising melanoma in canines. Ten dogs with spontaneously occurring melanomas were treated with PDT using BPD as the photosensitizer. BPD was injected intravenously at a dose of 1 mg/kg. Six hours later the treatment of PDT with 690 nm light was taken. Some larger tumors (>1.5 cm deep) were surgically debulked prior to PDT. No significant systemic toxicity or skin photosensitization was observed. PDT with BPD led to a complete response in 70{\%} (7 of 10) of these cases. 20{\%} (2 of 10) had a partial response, and 10{\%} (1 of 10) no response (<50{\%} reduction of tumor size). BPD-PDT appears to have advantages in the treatment of canine melanomas, and systemic toxicity is almost nonexistent. Further studies of the long term results are necessary before BPD-PDT can be used in humans.",
keywords = "Melanoma, Photodynamic therapy, Photosensitizer",
author = "Chang, {Cheng Jen} and Chang, {Chen Nun} and Hwang, {Tsann Lang}",
year = "2002",
month = "1",
day = "1",
language = "English",
volume = "35",
pages = "166--172",
journal = "Formosan Journal of Surgery",
issn = "1011-6788",
publisher = "臺灣外科醫學會",
number = "4",

}

TY - JOUR

T1 - The capabilities of benzoporphyrin

T2 - In vivo study of canine malignant melanomas with photodynamic therapy

AU - Chang, Cheng Jen

AU - Chang, Chen Nun

AU - Hwang, Tsann Lang

PY - 2002/1/1

Y1 - 2002/1/1

N2 - Human malignant melanomas are a kind of commonly occurring neoplasm with a clinical course of recurrence after surgical removal. This preliminary animal study seeks to evaluate the effect of benzoporphyrin derivative (BPD) in photodynamic therapy (PDT) for spontaneously arising melanoma in canines. Ten dogs with spontaneously occurring melanomas were treated with PDT using BPD as the photosensitizer. BPD was injected intravenously at a dose of 1 mg/kg. Six hours later the treatment of PDT with 690 nm light was taken. Some larger tumors (>1.5 cm deep) were surgically debulked prior to PDT. No significant systemic toxicity or skin photosensitization was observed. PDT with BPD led to a complete response in 70% (7 of 10) of these cases. 20% (2 of 10) had a partial response, and 10% (1 of 10) no response (<50% reduction of tumor size). BPD-PDT appears to have advantages in the treatment of canine melanomas, and systemic toxicity is almost nonexistent. Further studies of the long term results are necessary before BPD-PDT can be used in humans.

AB - Human malignant melanomas are a kind of commonly occurring neoplasm with a clinical course of recurrence after surgical removal. This preliminary animal study seeks to evaluate the effect of benzoporphyrin derivative (BPD) in photodynamic therapy (PDT) for spontaneously arising melanoma in canines. Ten dogs with spontaneously occurring melanomas were treated with PDT using BPD as the photosensitizer. BPD was injected intravenously at a dose of 1 mg/kg. Six hours later the treatment of PDT with 690 nm light was taken. Some larger tumors (>1.5 cm deep) were surgically debulked prior to PDT. No significant systemic toxicity or skin photosensitization was observed. PDT with BPD led to a complete response in 70% (7 of 10) of these cases. 20% (2 of 10) had a partial response, and 10% (1 of 10) no response (<50% reduction of tumor size). BPD-PDT appears to have advantages in the treatment of canine melanomas, and systemic toxicity is almost nonexistent. Further studies of the long term results are necessary before BPD-PDT can be used in humans.

KW - Melanoma

KW - Photodynamic therapy

KW - Photosensitizer

UR - http://www.scopus.com/inward/record.url?scp=0036631432&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036631432&partnerID=8YFLogxK

M3 - Article

VL - 35

SP - 166

EP - 172

JO - Formosan Journal of Surgery

JF - Formosan Journal of Surgery

SN - 1011-6788

IS - 4

ER -